In today's world, 5F-CUMYL-P7AICA is a topic that sparks great interest and debate. Whether in academic, professional or personal fields, 5F-CUMYL-P7AICA has become a relevant and topical topic. From its origins to its impact on today's society, 5F-CUMYL-P7AICA has generated a wide range of opinions and perspectives. In this article, we will explore various aspects related to 5F-CUMYL-P7AICA, from its historical background to its influence on popular culture. Additionally, we will discuss the implications and challenges that 5F-CUMYL-P7AICA represents in different contexts, as well as possible solutions and approaches to address them. Join us on this tour through the fascinating world of 5F-CUMYL-P7AICA!
![]() | |
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C22H26FN3O |
Molar mass | 367.468 g·mol−1 |
3D model (JSmol) | |
| |
|
5F-CUMYL-P7AICA (also known as CUMYL-5F-P7AICA or SGT-263) is a pyrrolopyridine-3-carboxamide based synthetic cannabinoid that has been sold as a designer drug. It was first identified by the EMCDDA in February 2015.